Detection of SMARCB1 gene mutations in Egyptian hepatocellular carcinoma patients using targeted next-generation sequencing: A pilot study

Molecular Evaluation of K-Ras Mutation in Egyptian Hepatocellular Carcinoma Patients

Molecular Assessment of DNA Methylation Biomarkers in Egyptian Hepatocellular carcinoma Patients.

Molecular Diagnosis of Hepatocellular Carcinoma in Egypt

EVALUATION OF CLINICAL UTILITY OF DETECTING CIRCULATING TUMOR DNA MUTATION GENE LOCUS TP53 RS28934571 USING REAL TIME PCR AND DROPLET DIGITAL PCR IN EGYPTIAN HEPATOCELLULAR CARCI

hTERT rs2736098 Genetic Variants and Susceptibility of Hepatocellular Carcinoma with Chronic Hepatitis C in the Egyptian Patients

TERT C228T MUTATION IN CIRCULATING TUMOR DNA AS A CLINICAL MARKER IN HEPATOCELLULAR CARCINOMA PATIENTS ATTENDING A TERTIARY HOSPITAL IN EGYPT: A CASE-CONTROL STUDY

Association Between DEPDC5 and PNPLA3 Variants and the Risk of Hepatocellular Carcinoma in HCV-Infected Patients in Egypt

Association of Circulatory Long Non-Coding RNA AFAP1-AS1 with Risk and Progression of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection

Long Noncoding RNA H19 rs3741219 Polymorphism and Risk of Hepatocellular Carcinoma in Egyptian Population